Nous Biosciences Inc.

Doylestown, PA Nous Biosciences

UEI
WS4XBLGG9X65
CAGE
9LP82
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
3805 Old Easton Rd #2224, Doylestown, PA 18902, USA
Website
nousbiosciences.com
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Nous Biosciences Inc.'s 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Combination of formulated dolcanatide, a guanylate cyclase-c agonist, with formulated atiprimod, a JAK-stat inhibitor,… Grant · R43DK141298 National Institute of Diabetes and Digestive and Kidney Diseases $716,078
Microsphere-based formulation of dolcanatide to prevent colon carcinogenesis - abstract colorectal cancer (CRC) ranks… Grant · R43CA291267 National Cancer Institute $708,023

Quick answers

What is Nous Biosciences Inc.'s UEI?

Nous Biosciences Inc.'s Unique Entity ID (UEI) in SAM.gov is WS4XBLGG9X65.

What is Nous Biosciences Inc.'s CAGE code?

Nous Biosciences Inc.'s CAGE code is 9LP82.

What is Nous Biosciences Inc.'s primary NAICS code?

Nous Biosciences Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).

Where is Nous Biosciences Inc. located?

Nous Biosciences Inc.'s physical address in SAM.gov is 3805 Old Easton Rd #2224, Doylestown, PA 18902, USA.

Is Nous Biosciences Inc. registered in SAM.gov?

Yes. Nous Biosciences Inc.'s SAM.gov registration is active through May 12, 2027.

What is Nous Biosciences Inc.'s most recent federal award?

Nous Biosciences Inc.'s most recent federal grant award is Combination of formulated dolcanatide, a guanylate cyclase-c agonist, with formulated atiprimod, a JAK-stat inhibitor,… (R43DK141298), from National Institute of Diabetes and Digestive and Kidney Diseases, on September 3, 2025.

On GovTribe

See Nous Biosciences Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login